AXIM Biotechnologies (AXIM) Financial Statements

151 Followers

AXIM Biotechnologies Financial Overview

AXIM Biotechnologies's market cap is currently $1.96M. The company's EPS TTM is $-0.012; its P/E ratio is -3.49; AXIM Biotechnologies is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 0.00	$ 70.46K	$ 39.52K	$ 8.88K	$ 60.46K
Gross Profit	$ -427.37K	$ -369.27K	$ 39.52K	$ -417.25K	$ 60.46K
Operating Income	$ -1.32M	$ -1.76M	$ -2.75M	$ -4.65M	$ -7.99M
EBITDA	$ -892.28K	$ -2.44M	$ -6.43M	$ -3.94M	$ -13.17M
Net Income	$ -1.04M	$ -3.51M	$ -8.06M	$ -5.96M	$ -16.52M
Balance Sheet
Cash & Short-Term Investments	$ 4.97K	$ 245.00	$ 156.46K	$ 47.28K	$ 452.96K
Total Assets	$ 2.88M	$ 3.45M	$ 4.12M	$ 4.21M	$ 5.32M
Total Debt	$ 7.78M	$ 6.64M	$ 5.89M	$ 5.66M	$ 6.72M
Net Debt	$ 7.78M	$ 6.64M	$ 5.74M	$ 5.62M	$ 6.27M
Total Liabilities	$ 14.24M	$ 13.87M	$ 11.78M	$ 9.04M	$ 7.66M
Stockholders' Equity	$ -11.37M	$ -10.42M	$ -7.66M	$ -4.83M	$ -2.34M
Cash Flow
Free Cash Flow	$ -686.21K	$ -857.90K	$ -1.03M	$ -2.05M	$ -2.54M
Operating Cash Flow	$ -686.21K	$ -855.06K	$ -1.03M	$ -2.04M	$ -2.49M
Investing Cash Flow	$ 0.00	$ -2.84K	$ 0.00	$ -8.71K	$ -50.49K
Financing Cash Flow	$ 657.50K	$ 701.68K	$ 1.14M	$ 1.65M	$ 2.53M

Currency in USD

AXIM Biotechnologies Earnings and Revenue History

Income Statement >

AXIM Biotechnologies Debt to Assets

Balance Sheet >

AXIM Biotechnologies Cash Flow

Cash Flow >

AXIM Biotechnologies Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >